Lamond David 4
4 · Quince Therapeutics, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Lamond David
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-02+47,587→ 47,587 totalExercise: $1.88Exp: 2035-01-02→ Common Stock (47,587 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the Issuer's Outside Director Compensation Policy.